drugset / Trial / NCT01446783

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

NCT01446783

Completed 15 enrolled Bispebjerg Hospital
RandomizedFactorialDouble-blindBasic science

Summary

The investigators want to inject insulin-like growth factor-I (IGF-I) into the patella tendon of Ehlers-Danlos patients and healthy controls to evaluate the response in collagen synthesis. Furthermore collagen synthesis is measured in muscle connective tissue and in skin. The hypothesis is that the connective tissue in Ehlers-Danlos patients is more compliant and poorer in collagen than healthy controls, but that collagen synthesis can be stimulated by IGF-I.

Timeline

Start
2011-09
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator mecasermin Protein / enzyme biologic 0.1 ml Other